Back to Search Start Over

High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer Phenotype12

Authors :
Johannes Haybaeck
Kensuke Kojima
Thomas Kolbe
Nicole Golob-Schwarzl
Vendula Svendova
Yujin Hoshida
Heimo Müller
Alexandra K. Kiemer
Michael G. Schimek
Stefanie Krassnig
Julia Judith Unterluggauer
Thomas M. Magin
Thomas Rülicke
Vineet Mahajan
Richard Moriggl
Kira Bettermann
Anita K. Mehta
Alexandra Lipfert
Andrea Thüringer
Cornelia Stumptner
K.P.R. Nilsson
Tatjana Stojakovic
Leopold F. Fröhlich
Sonja M. Kessler
Nabeel Bardeesy
Clemens Diwoky
Pavel Strnad
Xintong Chen
Source :
Translational Oncology, Translational Oncology, Vol 12, Iss 2, Pp 256-268 (2019)
Publication Year :
2018
Publisher :
Neoplasia Press, 2018.

Abstract

BACKGROUND amp; AIMS: Steatohepatitis (SH) and SH-associated hepatocellular carcinoma (HCC) are of considerable clinical significance. SH is morphologically characterized by steatosis, liver cell ballooning, cytoplasmic aggregates termedMallory-Denk bodies (MDBs), inflammation, and fibrosis at late stage. Disturbance of the keratin cytoskeleton and aggregation of keratins (KRTs) are essential for MDB formation. METHODS: Weanalyzed livers of aged Krt18(-/-) mice that spontaneously developed in the majority of cases SH-associated HCC independent of sex. Interestingly, the hepatic lipid profile in Krt18(-/-) mice, which accumulate KRT8, closely resembles human SH lipid profiles and shows that the excess of KRT8 over KRT18 determines the likelihood to develop SH-associated HCC linked with enhanced lipogenesis. RESULTS: Our analysis of the genetic profile of Krt18(-/-) mice with 26 human hepatoma cell lines and with data sets of amp;gt;300 patients with HCC, where Krt18(-/-) gene signatures matched human HCC. Interestingly, a high KRT8/18 ratio is associated with an aggressive HCC phenotype. CONCLUSIONS: We can prove that intermediate filaments and their binding partners are tightly linked to hepatic lipid metabolism and to hepatocarcinogenesis. We suggest KRT8/18 ratio as a novel HCC biomarker for HCC. Funding Agencies|Kurt und Senta Herrmann Stiftung; Austrian Genome Programme GEN-AU; DFG [MA1316-15, MA1316-17, MA1316-19, MA1316-21, INST 268/230-1]; German Research Foundation [STR 1095/4-2]; Else Kroner Exzellenzstipendium; Innovative Medicines Initiative Joint Undertaking from the European Unions Seventh Framework Programme (FP7/2007-2013) [115234]; EFPIA companies

Details

Language :
English
ISSN :
19365233
Volume :
12
Issue :
2
Database :
OpenAIRE
Journal :
Translational Oncology
Accession number :
edsair.doi.dedup.....6079c492ddfd500bb2b10ae9d60ce9d1